-transparent.png){kind=logo}
Concanavalin A is used as a mitogen for the stimulation of lymphocytes in vitro. It increases the proliferation of different populations of lymphocytes and activates the function of regulator lymphocytes. This effect appears to be modified in vivo in such a way that daily IV application prolongs survival times of allogeneic and xenogeneic kidney grafts significantly. The reason seems to be an influence on behavior, which is reflected in a pronounced peripheral lymphopenia. To support and investigate this mechanism, further combinations of antilymphocyte globulin, fox red blood cells, and Concanavalin A pretreatment were used in pilot studies.
Related Publications
H Welter, and
H Krause, and
C Hammer, and
W Brendel
November 1972,
Science (New York, N.Y.),
H Welter, and
H Krause, and
C Hammer, and
W Brendel
May 1976,
Transplantation,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
October 1987,
Transplantation proceedings,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
January 1976,
Langenbecks Archiv fur Chirurgie,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
November 1978,
Transplantation,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
August 1956,
Polski tygodnik lekarski,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
January 1972,
Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
November 1952,
Casopis lekaru ceskych,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
August 1975,
Transplantation,
H Welter, and
H Krause, and
C Hammer, and
W Brendel
January 2022,
Canadian journal of surgery. Journal canadien de chirurgie,
